NEW YORK, October 20, 2017 /PRNewswire/ --
If you want a Stock Review on RCM, RNVA, ATHN, or HQY then come over to http://dailystocktracker.com/register/ and sign up for your free customized report. DailyStockTracker.com shifts focus on R1 RCM Inc. (NASDAQ: RCM), Rennova Health Inc. (NASDAQ: RNVA), athenahealth Inc. (NASDAQ: ATHN), and HealthEquity Inc. (NASDAQ: HQY). These companies are part of the Healthcare Information Services industry, which consists of a set of corporations that provide data, products, and services to customers ranging from hospitals and physician practices to pharmaceutical and biotech companies to private individuals. Sign up today on DailyStockTracker.com and download our free research reports on these featured stocks at:
R1 RCM Inc.'s stock finished Thursday's session 0.55% lower at $3.61 with a total trading volume of 107,358 shares. The Company's shares have advanced 6.80% in the past month, 4.34% in the previous three months, and 60.44% since the start of this year. The stock is trading 6.38% above its 50-day moving average and 12.58% above its 200-day moving average. Additionally, shares of R1 RCM, which helps healthcare providers generate sustainable improvements in their operating margins and cash flows, while also enhancing patient, physician and staff satisfaction for customers, have a Relative Strength Index (RSI) of 54.72.
On October 18th, 2017, R1 RCM announced that it expects to release financial results for the three months ended September 30th, 2017 after market close on October 31st, 2017. The Company's management team will host a conference call at 4:30 p.m. ET that same day to discuss the results and business outlook. A live webcast of the call will be available under the Investor Relations section of the Company's website. RCM complete research report is just a click away at:
On Thursday, shares in West Palm Beach, Florida headquartered Rennova Health Inc. recorded a trading volume of 2.11 million shares, which was above their three months average volume of 113,320 shares. The stock ended the session 20.24% lower at $0.98. The Company's shares are trading 69.58% below their 50-day moving average. Moreover, shares of Rennova Health, which provides diagnostics and supportive software solutions to healthcare providers, have an RSI of 11.12.
On September 29th, 2017, Rennova Health announced that Big South Fork Medical Center had its two-day accreditation survey conducted by DNV as required by CMS. After receiving the final report from DNV, CMS will issue a Medicare number that is needed to secure payment from Medicare and Medicaid. Approximately 60% of the services provided in the hospital are payable by federal payers, and this number is required to receive payments and get credentialed with other insurers. The complimentary report on RNVA can be downloaded at:
Watertown, Massachusetts headquartered athenahealth Inc.'s shares closed the day 3.62% lower at $116.41. The stock recorded a trading volume of 911,117 shares, which was higher than its three months average volume of 571,670 shares. The Company's shares have gained 10.69% on an YTD basis. The stock is trading 7.74% below its 200-day moving average. Additionally, shares of athenahealth, which together with its subsidiaries, provides network-based medical record, revenue cycle, patient engagement, care coordination, and population health services for medical groups and health systems, have an RSI of 35.66.
On September 25th, 2017, athenahealth announced that it will hold a conference call on October 20th, 2017, at 8:00 a.m. ET. During the conference call, management will review highlights from the Company's Q3 2017 results, which will be announced via press release after the close of market trading on October 19th, 2017. The live conference call and webcast may be accessed under the Investors section of the Company's website. Sign up for your complimentary report on ATHN at:
Shares in Draper, Utah headquartered HealthEquity Inc. finished 0.38% lower at $49.94. The stock recorded a trading volume of 409,930 shares. The Company's shares have advanced 2.63% in the last one month, 5.40% in the previous three months, and 23.25% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 6.96% and 8.00%, respectively. Furthermore, shares of HealthEquity, which provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the US, have an RSI of 55.37. Download the research report for free on HQY at:
Daily Stock Tracker:
Daily Stock Tracker (DST) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. DST has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
DST has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please e-mail [email protected]. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by DST. DST is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
DST, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. DST, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, DST, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither DST nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via e-mail and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
E-mail: [email protected]
Phone number: +27(207)331-3313
Office Address: 377 Rivonia Boulevard, Rivonia, South Africa
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.